Litcius/Paper detail

Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia

Isabel Ramírez, Esther de la Viuda, Laura Baquedano, Pluvio Coronado, Plácido Llaneza, Nicolás Mendoza, Borja Otero, Sonia Sánchez, María Jesús Cancelo Hidalgo, José A. Páramo, Antonio Cano

2020Maturitas51 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePandemicHormonal contraceptionMenopauseAntithromboticEstrogenCoronavirus disease 2019 (COVID-19)Hormone therapyGynecologyHormoneObstetricsIntensive care medicineFamily planningInternal medicinePopulationDiseaseResearch methodologyInfectious disease (medical specialty)Breast cancerCancerEnvironmental healthCOVID-19 Impact on ReproductionCOVID-19 and healthcare impactsVenous Thromboembolism Diagnosis and Management
Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia | Litcius